Euveda Biosciences Overview
- Founded
- 2009
- Status
- Out of Business
- Latest Deal Type
- Out of Business
Euveda Biosciences General Information
Description
Provider of a microfluidic technologies platform intended to offer pharmaceutical related services. The company's microfluidic technologies platform develops innovative microfluidic cell-based assay technologies, enabling pharmaceutical companies to facilitate drug discovery and personalized medicine applications.
Contact Information
Website
www.euvedabiosciences.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Social/Platform Software
Pharmaceuticals
Primary Office
- 1450 South Rolling Road
- Baltimore, MD 21227
- United States
Euveda Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 00000 | Completed | Out of Business | |||
| 5. Grant | 01-Jan-2013 | 00000 | 00000 | Completed | Startup | |
| 4. Seed Round | 01-Jan-2012 | 00000 | 00000 | Completed | Startup | |
| 3. Grant | 15-Nov-2011 | 00000 | 00000 | Completed | Startup | |
| 2. Seed Round | 01-Jan-2011 | $750K | $750K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Euveda Biosciences Patents
Euveda Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150355165-A1 | Microfluidic grid-based design for high throughput assays | Granted | 11-Jun-2013 | 000000000000 | 0 |
| US-9656262-B2 | Microfluidic grid-based design for high throughput assays | Expired - Fee Related | 11-Jun-2013 | 000000000000 | 0 |
Euveda Biosciences Executive Team (4)
Euveda Biosciences Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andre Levchenko | Euveda Biosciences | Co-Founder & Chairman of Scientific Advisory Board | 000 0000 |